Stock listing
SET:APCO Asian Phytoceuticals Public Co., Ltd. (เอเชียน ไฟย์โตซูติคอลส์) หุ้น
Home listing (SET) of Asian Phytoceuticals Public Co., Ltd.
Follow Asian Phytoceuticals Public Co., Ltd. into a list and get an email when it puts out news.
Share price · SET:APCO
2.56 THB +0.02 (+0.8%)
Close on Nov 20, 2026
- Day range
- 2.44 – 2.56 THBNov 20, 2026
- Volume
- 90,001 sharesNov 20, 2026
- Market cap
- 1.54B THBAt the close on Nov 20, 2026 · price × 600.0M shares outstanding
- Traded on an average day
- 180,553 THBMedian day 43,616 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SET:APCO · THB, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 2.56 | +0.02 | +0.8% | 2.52 | 2.56 | 2.44 | 90,001 | |
| 2.54 | +0.04 | +1.6% | 2.50 | 2.54 | 2.40 | 247,200 | |
| 2.50 | 0.00 | 0.0% | 2.46 | 2.50 | 2.44 | 100,400 | |
| 2.50 | +0.02 | +0.8% | 2.48 | 2.50 | 2.42 | 92,000 | |
| 2.48 | -0.02 | -0.8% | 2.40 | 2.48 | 2.36 | 430,500 | |
| 2.50 | 0.00 | 0.0% | 2.50 | 2.50 | 2.48 | 12,710 | |
| 2.50 | 0.00 | 0.0% | 2.50 | 2.50 | 2.46 | 44,400 | |
| 2.50 | -0.02 | -0.8% | 2.50 | 2.50 | 2.48 | 3,509 | |
| 2.52 | +0.02 | +0.8% | 2.50 | 2.52 | 2.50 | 56,101 | |
| 2.50 | +0.02 | +0.8% | 2.48 | 2.50 | 2.46 | 59,083 | |
| 2.48 | -0.02 | -0.8% | 2.48 | 2.48 | 2.30 | 176,500 | |
| 2.50 | 0.00 | 0.0% | 2.48 | 2.50 | 2.46 | 37,500 | |
| 2.50 | 0.00 | 0.0% | 2.50 | 2.50 | 2.46 | 134,600 | |
| 2.50 | -0.02 | -0.8% | 2.46 | 2.66 | 2.46 | 219,410 | |
| 2.52 | 0.00 | 0.0% | 2.50 | 2.52 | 2.48 | 70,919 | |
| 2.52 | 0.00 | 0.0% | 2.50 | 2.52 | 2.44 | 200,639 | |
| 2.52 | 0.00 | 0.0% | 2.48 | 2.52 | 2.48 | 30,300 | |
| 2.52 | +0.04 | +1.6% | 2.48 | 2.52 | 2.46 | 76,200 | |
| 2.48 | -0.02 | -0.8% | 2.46 | 2.50 | 2.46 | 28,500 | |
| 2.50 | 0.00 | 0.0% | 2.50 | 2.52 | 2.48 | 98,918 | |
| 2.50 | -0.02 | -0.8% | 2.50 | 2.52 | 2.48 | 253,607 | |
| 2.52 | 0.00 | 0.0% | 2.48 | 2.52 | 2.48 | 126,500 | |
| 2.52 | 0.00 | 0.0% | 2.48 | 2.52 | 2.48 | 65,702 | |
| 2.52 | 0.00 | 0.0% | 2.50 | 2.52 | 2.48 | 99,000 | |
| 2.52 | 0.00 | 0.0% | 2.48 | 2.52 | 2.48 | 30,100 | |
| 2.52 | 0.00 | 0.0% | 2.50 | 2.52 | 2.48 | 30,000 | |
| 2.52 | 0.00 | 0.0% | 2.48 | 2.52 | 2.46 | 156,820 | |
| 2.52 | 0.00 | 0.0% | 2.52 | 2.52 | 2.50 | 75,087 | |
| 2.52 | -0.02 | -0.8% | 2.50 | 2.54 | 2.50 | 10,810 | |
| 2.54 | 0.00 | 0.0% | 2.52 | 2.54 | 2.52 | 18,043 | |
| 2.54 | 0.00 | 0.0% | 2.50 | 2.54 | 2.50 | 11,200 | |
| 2.54 | +0.02 | +0.8% | 2.48 | 2.54 | 2.48 | 31,900 | |
| 2.52 | 0.00 | 0.0% | 2.52 | 2.52 | 2.48 | 55,730 | |
| 2.52 | -0.02 | -0.8% | 2.54 | 2.56 | 2.50 | 14,502 | |
| 2.54 | 0.00 | 0.0% | 2.52 | 2.54 | 2.50 | 16,705 | |
| 2.54 | 0.00 | 0.0% | 2.54 | 2.54 | 2.52 | 8,805 | |
| 2.54 | 0.00 | 0.0% | 2.52 | 2.56 | 2.50 | 39,600 | |
| 2.54 | 0.00 | 0.0% | 2.52 | 2.56 | 2.52 | 36,304 | |
| 2.54 | +0.02 | +0.8% | 2.52 | 2.54 | 2.50 | 38,217 | |
| 2.52 | -0.02 | -0.8% | 2.52 | 2.54 | 2.50 | 100,931 | |
| 2.54 | +0.02 | +0.8% | 2.54 | 2.58 | 2.50 | 21,242 | |
| 2.52 | -0.06 | -2.3% | 2.58 | 2.58 | 2.50 | 53,142 | |
| 2.58 | +0.04 | +1.6% | 2.52 | 2.58 | 2.52 | 10,401 | |
| 2.54 | -0.04 | -1.6% | 2.54 | 2.56 | 2.52 | 43,616 | |
| 2.58 | 0.00 | 0.0% | 2.58 | 2.58 | 2.56 | 2,918 | |
| 2.58 | 0.00 | 0.0% | 2.54 | 2.58 | 2.54 | 8,408 | |
| 2.58 | +0.04 | +1.6% | 2.50 | 2.58 | 2.50 | 43,601 | |
| 2.54 | 0.00 | 0.0% | 2.52 | 2.54 | 2.50 | 5,605 | |
| 2.54 | +0.02 | +0.8% | 2.52 | 2.54 | 2.50 | 21,785 | |
| 2.52 | 0.00 | 0.0% | 2.52 | 2.52 | 2.48 | 97,114 | |
| 2.52 | -0.04 | -1.6% | 2.54 | 2.58 | 2.52 | 13,100 | |
| 2.56 | -0.02 | -0.8% | 2.56 | 2.58 | 2.52 | 54,119 | |
| 2.58 | 0.00 | 0.0% | 2.56 | 2.58 | 2.56 | 3,602 |
- Ticker
- SET:APCO
- Asset type
- Stock
- Sector
- Consumer goods
- Industry
- Household & personal care
- Exchange
- SET
- Currency
- THB
What changed lately
Latest deck · Aug 27, 2026
Q2 2026 Earnings Presentation
Earnings · 64 slides
Latest news
Asian Phytoceuticals Public Co., Ltd. on 6ix
- Sector
- Consumer goods
- Industry
- Household & personal care
- News releases
- 2 in all · newest Apr 18, 2022 · oldest 2022
- Decks
- 27 decks · latest Aug 27, 2026
Where Asian Phytoceuticals Public Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SET:APCO เอเชียน ไฟย์โตซูติคอลส์ · Home listing · This page | SET | Thailand | THB |
| SET:APCO.R เอเชียน ไฟย์โตซูติคอลส์ | SET | Thailand | THB |
| SET:APCO.F เอเชียน ไฟย์โตซูติคอลส์ | SET | Thailand | THB |
Valuation
P/E 26.6× against a median of 11.9×: the highest of 8 Household & personal care companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 1.20B THB
- P/E
- 26.6×
- EV/sales
- 6.1×
- EV/EBITDA
- 16.2×
- Price/book
- 2.9×
- Gross margin
- 84.5%
- Operating margin
- 27.7%
- Net margin
- 29.4%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Household & personal care: the 10 companies nearest in size, of 134 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Asian Phytoceuticals Public Co., Ltd. · SET:APCO | US$45.23M | US$35.29M | 26.6× | 6.1× | 16.2× | 2.9× | 29.4% | 0.0× | n/a |
| Ming Fai International Holdings Limited · HKEX:3828 | US$60.89M | US$16.13M | 4.7× | 0.1× | 0.7× | 0.3× | 4.5% | 0.0× | n/a |
| BBIA Co., Ltd. · KRX:451250 | US$57.00M | US$39.61M | 10.9× | 0.7× | 5.5× | 1.7× | 9.1% | 0.0× | n/a |
| Aromatica Co., Ltd. · KRX:0015N0 | US$51.76M | US$37.09M | 11.9× | 0.8× | 6.3× | 1.5× | 10.0% | 0.0× | n/a |
| China Ludao Technology Co. Ltd. · HKEX:2023 | US$48.94M | US$173.3M | 5.8× | 1.0× | 12.5× | 0.5× | 5.0% | 1.5× | n/a |
| Meiwu Technology Company Limited · NASDAQ:WNW | US$43.31M | US$25.47M | n/a | 3.6× | n/a | 0.9× | −262.5% | 0.0× | 0.95 |
| Revolution Beauty Group plc · LSE:REVB | US$43.23M | US$77.77M | n/a | 0.6× | n/a | n/a | −30.2% | n/a | n/a |
| Kuangli Bio-Tech Holdings Co., Ltd. · TWSE:6431 | US$42.10M | US$46.64M | n/a | 4.2× | n/a | 2.8× | −52.4% | 1.0× | n/a |
| Dr. Miele Cosmed Group S.A. · GPW:DMG | US$37.82M | US$52.44M | 12.4× | 0.4× | 6.3× | 0.6× | 2.5% | 0.2× | n/a |
| China Golden Classic Group Ltd. · HKEX:8281 | US$35.08M | US$25.53M | 20.2× | 0.6× | 6.0× | 0.9× | 4.2% | 0.0× | n/a |
| Monalisa Co., Ltd · KRX:012690 | US$34.36M | US$22.72M | 21.7× | 0.2× | 4.5× | 0.5× | 1.6% | 0.0× | n/a |
| Median of the others | US$43.27M | US$38.35M | 11.9× | 0.7× | 6.0× | 0.9× | 3.4% | 0.0× | 0.95 |
Team and board
Officers
| Officer | Role |
|---|---|
| Pichaet Wiriyachitra | Director / Chairman of Executive Committee / Chief Executive Officer |
| Assoc.Prof.Arunee Wiriyachitra | Director / Executive Committee |
| Dr.Jingjai Hanchanlash | Director / Executive Committee |
Board
| Director | Role |
|---|---|
| Maleeratna Plumchitchome | Independent Director / Chairperson of the Board / Chairperson of the Audit Committee |
| Assoc.Prof.Arunee Wiriyachitra | Director / Executive Committee |
| Assoc.Prof.Dr.Varakorn Samakoses | Independent Director / Audit Committee |
| Dr.Jingjai Hanchanlash | Director / Executive Committee |
| Montien Sirisoonthornlak | Director |
| Pichaet Wiriyachitra | Director / Chairman of Executive Committee / Chief Executive Officer |
| Prof.Dr.Praipol Koomsup | Independent Director / Audit Committee |
Events
| Quarter | Results |
|---|---|
| Q1 2025 | May 9, 2025 |
| Q4 2024 | Mar 4, 2025 |
| Q3 2024 | Nov 13, 2024 |
| Q2 2024 | Aug 9, 2024 |
| Q1 2024 | May 14, 2024 |
| Q4 2023 | Feb 28, 2024 |
| Q3 2023 | Nov 10, 2023 |
| Q2 2023 | Aug 9, 2023 |
| Q1 2023 | May 12, 2023 |
| Q4 2022 | Feb 22, 2023 |
All 18 quarters
| Quarter | Results |
|---|---|
| Q3 2022 | Nov 9, 2022 |
| Q2 2022 | Aug 9, 2022 |
| Q1 2022 | May 13, 2022 |
| Q4 2021 | Feb 28, 2022 |
| Q3 2021 | Dec 1, 2021 |
| Quarter to Jun 30, 2021 | Aug 10, 2021 |
| Quarter to Mar 31, 2021 | May 13, 2021 |
| Quarter to Dec 31, 2020 | Feb 25, 2021 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 64 slides | Aug 27, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 46 slides | May 28, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 5 slides | Mar 12, 2026 |
| Corporate Update (November 2025) | Corporate update | 45 slides | Nov 27, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 31 slides | Aug 27, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 30 slides | May 27, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 55 slides | Mar 7, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 23 slides | Nov 28, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 36 slides | Sep 2, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 36 slides | May 31, 2024 |
All 27 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (April 2024) | Shareholder meeting | 24 slides | Apr 22, 2024 |
| Q2 2023 Earnings Presentation | Earnings | 32 slides | Sep 13, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 46 slides | Jun 9, 2023 |
| Shareholder Meeting (April 2023) | Shareholder meeting | 34 slides | Apr 26, 2023 |
| FY2022 Earnings Presentation | Earnings | 50 slides | Mar 3, 2023 |
| Q3 2022 Earnings Presentation | Earnings | 23 slides | Dec 2, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 22 slides | May 30, 2022 |
| Q3 2021 Earnings Presentation | Earnings | 34 slides | Dec 7, 2021 |
| Q2 2021 Earnings Presentation | Earnings | 40 slides | Sep 10, 2021 |
| Q1 2021 Earnings Presentation | Earnings | 63 slides | Jun 14, 2021 |
| Q3 2020 Earnings Presentation | Earnings | 61 slides | Dec 2, 2020 |
| Q3 2019 Earnings Presentation | Earnings | 91 slides | Dec 4, 2019 |
| Q1 2019 Earnings Presentation | Earnings | 29 slides | May 24, 2019 |
| FY2018 Earnings Presentation | Earnings | 36 slides | Mar 25, 2019 |
| Q3 2018 Earnings Presentation | Earnings | 22 slides | Nov 29, 2018 |
| Q2 2018 Earnings Presentation | Earnings | 52 slides | Sep 4, 2018 |
| Q1 2018 Earnings Presentation | Earnings | 41 slides | May 24, 2018 |
Financials
Annual, in THB
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 200.2M | 210.8M | 292.8M | 250.4M | 223.4M | 247.7M | 247.7M | 369.8M | 415.7M | 421.4M |
| Cost of revenue | 31.1M | 41.0M | 57.2M | 47.9M | 46.3M | 52.9M | 51.8M | 64.9M | 67.5M | 59.6M |
| Gross profit | 169.0M | 169.9M | 235.5M | 202.4M | 177.1M | 194.9M | 195.8M | 304.9M | 348.3M | 361.8M |
| Research and development | 4.73M | 5.05M | 7.21M | 6.10M | 5.82M | 6.44M | 162.5K | 1.63M | 16.6M | 9.26M |
| Selling, general and administrative | 62.0M | 67.2M | 66.3M | 68.4M | 70.4M | 75.9M | 78.2M | 80.4M | 84.7M | 85.6M |
| Operating income | 53.6M | 53.1M | 116.9M | 88.0M | 73.8M | 75.5M | 64.9M | 110.1M | 122.8M | 164.3M |
| Depreciation and amortization | 19.6M | 20.7M | 22.2M | 23.2M | 27.0M | 31.2M | 13.6M | 13.8M | 14.5M | 17.0M |
| EBITDA | 73.2M | 73.8M | 139.0M | 111.3M | 100.8M | 106.8M | 78.5M | 123.9M | 137.2M | 181.3M |
| Interest expense | 1.61M | 1.59M | 661.3K | 566.2K | 864.3K | 476.5K | 0 | 0 | 0 | 0 |
| Income before tax | 69.7M | 68.0M | 133.2M | 100.5M | 85.5M | 87.1M | 72.4M | 117.7M | 131.6M | 164.3M |
| Income tax | 13.1M | 12.2M | 24.4M | 19.3M | 16.8M | 17.1M | 14.5M | 22.9M | 23.4M | 32.8M |
| Net income | 55.4M | 54.7M | 107.5M | 80.9M | 68.7M | 70.0M | 57.9M | 94.7M | 108.2M | 131.4M |
| Earnings per share, basic | 0.09 | 0.09 | 0.18 | 0.13 | 0.11 | 0.12 | 0.10 | 0.16 | 0.18 | 0.24 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 102.5M | 62.4M | 125.6M | 82.1M | 98.6M | 100.2M | 160.3M | 182.4M | 244.3M | 222.5M |
| Short-term investments | 257.2M | 289.3M | 125.6M | 97.0M | 68.3M | 71.8M | 319.5M | 313.4M | 270.5M | 315.5M |
| Receivables | 3.77M | 5.49M | 4.22M | 4.21M | 3.29M | 5.29M | 1.44M | 5.25M | 4.55M | 4.97M |
| Inventory | 69.1M | 57.0M | 44.3M | 52.5M | 58.6M | 60.3M | 61.0M | 65.5M | 51.1M | 48.2M |
| Current assets | 438.0M | 415.5M | 300.8M | 237.5M | 231.1M | 240.7M | 544.5M | 569.4M | 573.6M | 595.6M |
| Property, plant and equipment | 64.0M | 91.2M | 113.4M | 71.4M | 83.6M | 93.8M | 106.7M | |||
| Total assets | 631.1M | 636.0M | 704.7M | 680.1M | 680.5M | 696.8M | 629.8M | 665.7M | 678.8M | 711.2M |
| Accounts payable | 1.01M | 765.7K | 1.20M | 635.8K | 1.99M | 630.8K | 690.2K | 1.74M | 1.55M | 1.75M |
| Current liabilities | 40.4M | 38.6M | 46.2M | 45.1M | 47.8M | 48.9M | 31.2M | 36.9M | 37.8M | 50.3M |
| Total debt | 13.7M | 24.1M | 35.7M | 13.8M | 34.2M | 50.0M | ||||
| Total liabilities | 70.9M | 76.3M | 92.3M | 69.6M | 85.5M | 101.3M | 50.6M | 51.6M | 50.5M | 62.1M |
| Shareholders' equity | 557.0M | 556.8M | 609.7M | 608.0M | 595.0M | 595.5M | 579.2M | 614.2M | 628.3M | 649.1M |
| Shares outstanding | 600.0M | 600.0M | 599.8M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 600.0M | 554.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 60.1M | 37.7M | 124.1M | 100.2M | 84.4M | 86.7M | 71.7M | 87.2M | 102.2M | 124.7M |
| Capital spending | -799.0K | -2.31M | -4.10M | -322.2K | -1.17M | -4.18M | -1.21M | -3.43M | -1.78M | -1.34M |
| Free cash flow | 59.3M | 35.4M | 120.0M | 99.9M | 83.2M | 82.6M | 70.5M | 83.8M | 100.5M | 123.4M |
| Cash from investing | 50.5M | 23.3M | 12.8M | -28.8M | 4.95M | -70.7M | -918.0K | -41.2M | 48.6M | -64.7M |
| Cash from financing | -70.4M | -124.2M | -109.7M | -87.8M | -91.0M | -76.2M | -92.9M | -108.0M | -129.0M | -51.3M |
| Dividends paid | -55.2M | -107.9M | -92.9M | -74.0M | -72.0M | -57.0M | -92.9M | -108.0M | -129.0M | -95.3M |
| Share buybacks | 44.0M | |||||||||
| Change in cash | 40.1M | -63.3M | 43.5M | -16.4M | -1.61M | -60.1M | -22.1M | -61.9M | 21.8M | 8.69M |
Cap table
Built by 6ix from Asian Phytoceuticals Public Co., Ltd.’s releases
- Common shares
- 600,000,000
- Fully diluted
- 600,000,000
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 600,000,000 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 600,000,000 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Assoc.Prof.Arunee Wiriyachitra | Director / Executive Committee · Since at least Nov 4, 2026 |
| Assoc.Prof.Dr.Varakorn Samakoses | Independent Director / Audit Committee · Since at least Nov 4, 2026 |
| Dr.Jingjai Hanchanlash | Director / Executive Committee · Since at least Nov 4, 2026 |
| Maleeratna Plumchitchome | Independent Director / Chairperson of the Board / Chairperson of the Audit Committee · Since at least Nov 4, 2026 |
| Montien Sirisoonthornlak | Director · Since at least Nov 4, 2026 |
| Pichaet Wiriyachitra | Director / Chairman of Executive Committee / Chief Executive Officer · Since at least Nov 4, 2026 |
| Prof.Dr.Praipol Koomsup | Independent Director / Audit Committee · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Asian Phytoceuticals Public Co., Ltd.